Patent US1775407A successfully refreshed from Google Patents.
Patent US4038279A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4038279A Expired / Lapsed US ⏱️ 0.0 years remaining

N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof

Assignee: Boehringer Ingelheim GmbH
•
Filing: 1975-12-01
•
Granted: 1977-07-26
•
Expires: 1995-12-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula ##STR1## wherein R is phenyl; phenyl having one or two substituents attached thereto, said substituents being selected from the group consisting of alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkylthio of 1 to 4 carbon atoms, chlorine and trifluoromethyl; naphthyl; tetrahydronaphthyl; indanyl; pyridyl; isoquinolyl; or thiazolyl; R 1 is ##STR2## where B is ##STR3## or ##STR4## R 3 is hydrogen, alkyl of 1 to 4 carbon atoms, R 4 and R 5 are each hydrogen or alkyl of 1 to 4 carbon atoms, and Q is oxygen or two hydrogens, R 2 is hydrogen, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen, A is a single carbon-to-carbon bond or --OCH 2 --, R 6 is hydrogen, hydroxyl, alkoxy of 1 to 4 carbon atoms or alkanoyloxy of 1 to 4 carbon atoms, and m is 0, 1, 2, 3, 4 or 5, but other than 0 when R 6 is hydroxyl, And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as CNS-depressants, adrenolytics, antiphologistics, analgesics, antihistaminic and anticholesteremics.

Inventors

  • 👤 Ernst-Otto Renth
  • 👤 Anton Mentrup
  • 👤 Kurt Schromm
  • 👤 Peter Danneberg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 12:55
CPC Classifications
C; C07; C07D; C07D207/00; C07D207/02; C07D207/18; C07D207/22; C07D207/24; C07D207/26; C07D207/263; C07D207/27; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 140 words
A racemic or optically active compound of the formula ##STR41## wherein R is phenyl; phenyl having one or two substituents attached thereto, said substituents being selected from the group consisting of alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkylthio of 1 to 4 carbon atoms, chlorine and trifluoromethyl; naphthyl; tetrahydronaphthyl; indanyl; pyridyl, quinolyl; or thiazolyl; R 2 is hydrogen, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen; A is a single carbon-to-carbon bond or --OCH 2 --; R 6 is hydrogen, hydroxyl, alkoxy of 1 to 4 carbon atoms or alkanoyloxy of 1 to 4 carbon atoms; and m is 0, 1, 2, 3, 4 or 5, but other than 0 when R 6 is hydroxyl; or a non-toxic, pharmacologically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 140 words
A racemic or optically active compound of the formula ##STR41## wherein R is phenyl; phenyl having one or two substituents attached thereto, said substituents being selected from the group consisting of alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkylthio of 1 to 4 carbon atoms, chlorine and trifluoromethyl; naphthyl; tetrahydronaphthyl; indanyl; pyridyl, quinolyl; or thiazolyl; R 2 is hydrogen, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen; A is a single carbon-to-carbon bond or --OCH 2 --; R 6 is hydrogen, hydroxyl, alkoxy of 1 to 4 carbon atoms or alkanoyloxy of 1 to 4 carbon atoms; and m is 0, 1, 2, 3, 4 or 5, but other than 0 when R 6 is hydroxyl; or a non-toxic, pharmacologically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 17 words
A compound of claim 1, which is N-[p-(2-oxopiperidino)-phenethyl]-N'-phenyl-piperazine or a non-toxic, pharmacologically acceptable acid addition salt thereof.
Claim 4
Dependent Claim 17 words
A compound of claim 1, which is N-[p-(2-oxopiperidino)-phenethyl]-N'-2-qunolyl-piperazine or a non-toxic, pharmacologically acceptable acid addition salt thereof.

References Cited (Backward Citations)

US3941789A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-07-25 1981-01-24 1981-07-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-07-25 1985-01-24 1985-07-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-07-25 1989-01-24 1989-07-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag